交通医学

参考文献

[1] HUNTER D J,BIE RMA-ZEINSTRA S. Osteoarthritis[J].Lancet,2019,393(10182):1745-1759.

[2] ALTMAN R D. Early management of osteoarthritis[J]. Am J Manag Care,2010,16(Suppl):S41-S47.

[3] FELSON D T,NEVITT M C. The effects of estrogen on osteoarthritis[J]. Curr Opin Rheumatol,1998,10(3):269-272.

[4] FERNANDES T L,GOMOLL A H,LATTERMANN C,et al.Macrophage:apotential target on car tilage regeneration[J].Front Immunol,2020,11:111.

[5] CONAGHAN P G,COOK A D,HAMILTON J A,et al. Therapeutic options for targeting inflammatory osteoarthritis pain[J]. Nat Rev Rheumatol,2019,15(6):355-363.

[6] O’NEILL T W,FELSON D T. Mechanisms of Osteoarthritis(OA)Pain[J]. Curr Osteoporos Rep,2018,16(5):611-616.

[7] GIORGINO R,ALBANO D,FUSCO S,et al. Knee osteoarthritis:epidemiology,pathogenesis,and mesenchymal stem cells:what else is new? an update[J]. Int J Mol Sci,2023,24(7):6405.

[8] WANG Y,ZHAO X,LIU-BRYAN R. Role of TLR2 and TLR4 in regulation of articular chondrocyte homeostasis[J].Osteoarthritis Cartilage,2020. 28(5):669-674.

[9] SCANZELLO C R,PLAAS A,CROW M K. Innate immune system activation in osteoarthritis:is osteoarthritis a chronic wound[J]? Curr Opin Rheumatol,2008,20(5):565-572.

[10] NEDUNCHEZHIYAN U,VARUGHESE I,SUN A R,et al.Obesity,inflammation,and immune system in osteoarthritis[J]. Front Immunol,2022,13:907750.

[11] SEBASTIAN A,HUM N R,MCCOOL J L,et al. Single-cell RNA-Seq reveals changes in immune landscape in post-traumatic osteoarthritis[J]. Front Immunol,2022,13:938075.

[12] LV Z,XU X,SUN Z,et al. TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathway[J]. Cell Death Dis,2021,12(6):504.

[13] PANG L,JIN H,LU Z,et al. Treatment with mesenchymal stem cell-derived nanovesicle-containing gelatin methacryloy-lhydrogels alleviates osteoarthritis by modulating chondrogenesis and macrophage polarization[J]. Adv Healthc Mater,2023,12(17):e2300315.

[14] ZHENG M,ZHU Y,WEI K,et al. Metformin attenuates the inflammatory response via the regulation of synovial M1macrophage in osteoarthritis[J]. Int J Mol Sci,2023,24(6):5355.

[15] KNIGHTS A J,REDDING S J,MAERZ T. Inflammation in osteoarthritis:the latest progress and ongoing challenges[J]. Curr Opin Rheumatol,2023,35(2):128-134.

[16] GAO C,PU H,ZENG Y,et al. The causal relationship between immune cells and knee osteoarthritis:Mendelian randomization study[J]. BMC Musculoskelet Disord,2025,26(1):504.

[17] LOUCKS A,MAERZ T,HANKENSON K,et al. The multifaceted role of mast cells in joint inflammation and arthritis[J]. Osteoarthritis Cartilage,2023,31(5):567-575.

[18] LIU Y ,LU T ,LIU Z ,et al. Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis[J]. Front Immunol,2022,13:936606.

[19] LIAO C R,WANG S N,ZHU S Y,et al. Advanced oxidation protein products increase TNF-α and IL-1β expression in chondrocytes via NADPH oxidase 4 and accelerate cartilage degeneration in osteoarthritis progression[J]. Redox Biol,2020,28:101306.

[20] HUEBNER K,FRANK R M,GETGOOD A. Ortho-biologics for osteoarthritis[J]. Clin Sports Med,2019,38(1):123-141.

[21] FRANGOS T,MARET W. Zinc and cadmium in the aetiology and pathogenesis of osteoarthritis and rheumatoid arthritis[J]. Nutrients,2020,13(1):E53.

[22] FRANCISCO V,RUIZ-FERNáNDEZ C,PINO J,et al.Adipokines:Linking metabolic syndrome,the immune system,and arthritic diseases[J]. Biochem Pharmacol,2019,165:196-206.

[23] RAHMAN S O,BARIGUIAN F,MOBASHERI A. The potential role of probiotics in the management of osteoarthritis pain:current status and future prospects[J]. Curr Rheumatol Rep,2023,25(12):307-326.

[24] RIZZO M G,BEST T M,HUARD J,et al. Therapeutic perspectives for inflammation and senescence in osteoarthritis using mesenchymal stem cells,mesenchymal stem cell-derived extracellular vesicles and senolytic agents[J]. Cells,2023,12(10):1421.

[25] SUN Y,ZUO Z,KUANG Y. An emerging target in the battle against osteoarthritis:macrophage polarization[J]. Int J Mol Sci,2020,21(22):E8513.

[26] YAN J,FENG G,YANG Y,et al. Nintedanib ameliorates osteoarthritis in mice by inhibiting synovial inflammation and fibrosis caused by M1 polarization of synovial macrophages via the MAPK/PI3K-AKT pathway[J]. FASEB J,2023,37(10):e23177.

[27] VAN den Bosch M H J. Inflammation in osteoarthritis:is it time to dampen the alarm(in)in this debilitating disease[J]? Clin Exp Immunol,2019,195(2):153-166.

[28] PENG L,WEI Y,SHAO Y,et al. The emerging roles of CCN3 protein in immune-related diseases[J]. Mediators Inflamm,2021,2021:5576059.

[29] LU J,ZHANG H,PAN J,et al. Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways[J]. Arthritis Res Ther,2021,23(1):142.

[30] VALERIO M S,EDWARDS J B,DOLAN C P,et al. Effect of targeted cytokine inhibition on progression of post-traumatic osteoarthritis following intra-articular fracture[J]. Int J MolSci,2023,24(17):13606.

[31] ZHOU K,YANG C L,SHI K,et al. Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage[J]. Biomaterials,2023,295:122036.

[32] YAN Y,LU A,DOU Y,et al. Nanomedicines reprogram synovial macrophages by scavenging nitric oxide and silencing CA9 in progressive osteoarthritis[J]. AdvSci(Weinh),2023,10(11):e2207490.

[33] BOFFA A,PERUCCA ORFEI C,SOURUGEON Y,et al.Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 2:bone marrow-derived cell-based injectable therapies[J]. Knee Surg Sports Traumatol Arthrosc,2023,31(8):3230-3242.

[34] JABBARI M,BARATI M,BARATI M,et al. Is collagen supplementation friend or foe in rheumatoid arthritis and osteoarthritis? A comprehensive systematic review[J]. Int J Rheum Dis,2022,25(9):973-981.

[35] LI D,RUAN G,ZHANG Y,et al. Metformin attenuates osteoarthritis by targeting chondrocytes,synovial macrophages and adipocytes[J]. Rheumatology(Oxford),2023,62(4):1652-1661.

[36] SOHN H S,CHOI J W,JHUN J,et al. Tolerogenic nanoparticles induce type II collagen-specific regulatory T cells and ameliorate osteoarthritis[J]. Sci Adv,2022,8(47):eabo5284.

[37] LIANG C,WU S,XIA G,et al. Engineered M2a macrophages for the treatment of osteoarthritis[J]. Front Immunol,2022,13:1054938.

[38] ALAHDAL M,ZHANG H,HUANG R,et al. Potential efficacy of dendritic cell immunomodulation in the treatment of osteoarthritis[J]. Rheumatology(Oxford),2021,60(2):507-517.

[39] LUO H,ZHU Y,GUO B,et al. Causal relationships between CD25 on immune cells and hip osteoarthritis[J]. Front Immunol,2023,14:1247710.

[40]杨定龙，张志强.辅助性T细胞在骨关节炎发病机制中的作用[J].中国修复重建外科杂志，2020,34(7):932-938.